Made for older adults, those in cancer treatment and cancer survivors, our products are optimized for safer relief and reduced side effects.
Every product we sell ships right to your door and comes with free, clinician-led phone support.
Our plans provide clinically responsible, ongoing product, dose and use guidance.
All based on your symptoms, relevant aspects of your medical record, other meds in use, your daily schedule and your regular feedback. And you get 10% off all products in your plan.
EO is recommended by clinicians at leading healthcare centers, including Mayo Clinic, Mount Sinai Hospital, Northwell Health, Penn Medicine and UVA Health - as well as by leading older adult and cancer advocacy organizations.
Get to know him and EO though his story of cancer treatment & survivorship.
Watch Video
A pioneering palliative care clinician and researcher, Dr. Worster is currently Director, Supportive Oncology at Jefferson Health in Philadelphia. She is a graduate of Temple University School of Medicine and completed her fellowship in palliative care and pain management at MGH Brigham and Dana Farber Cancer Center in Boston.
An internationally recognized cannabis clinician and educator, Dr. Caplan has overseen the care of over 18,000 cannabis patients and developed protocols that have benefited tens of thousands more. He is a graduate of Tufts University School of Medicine and completed his residency in family medicine at Boston Medical Center.
A leading clinical geriatric pharmacist and educator, Dr. Hajjar serves as Professor and Director of the Population Health Pharmacy Program at the Jefferson College of Pharmacy. She received her PharmD at Duquesne University and completed a fellowship in Geriatric Pharmacoepidemiology at the University of Minnesota.
A pioneering palliative care clinician and researcher, Dr. Worster is currently Director, Supportive Oncology at Jefferson Health in Philadelphia. She is a graduate of Temple University School of Medicine and completed her fellowship in palliative care and pain management at MGH Brigham and Dana Farber Cancer Center in Boston.
A pioneering palliative care clinician and researcher, Dr. Worster is currently Director, Supportive Oncology at Jefferson Health in Philadelphia. She is a graduate of Temple University School of Medicine and completed her fellowship in palliative care and pain management at MGH Brigham and Dana Farber Cancer Center in Boston.
An internationally recognized cannabis clinician and educator, Dr. Caplan has overseen the care of over 18,000 cannabis patients and developed protocols that have benefited tens of thousands more. He is a graduate of Tufts University School of Medicine and completed his residency in family medicine at Boston Medical Center.
An internationally recognized cannabis clinician and educator, Dr. Caplan has overseen the care of over 18,000 cannabis patients and developed protocols that have benefited tens of thousands more. He is a graduate of Tufts University School of Medicine and completed his residency in family medicine at Boston Medical Center.
A leading clinical geriatric pharmacist and educator, Dr. Hajjar serves as Professor and Director of the Population Health Pharmacy Program at the Jefferson College of Pharmacy. She received her PharmD at Duquesne University and completed a fellowship in Geriatric Pharmacoepidemiology at the University of Minnesota.
A leading clinical geriatric pharmacist and educator, Dr. Hajjar serves as Professor and Director of the Population Health Pharmacy Program at the Jefferson College of Pharmacy. She received her PharmD at Duquesne University and completed a fellowship in Geriatric Pharmacoepidemiology at the University of Minnesota.
It’s why we’ve attracted a team of committed investors and advisors, including Bill Van Faasen, former CEO of Blue Cross Blue Shield Massachusetts, Kristi Savacool, former CEO of Aon Hewitt and Dr. Regina Benjamin, former US Surgeon General.
Learn More About UsWhat symptoms can cannabis help me manage? Will it interact with my other treatments? Which THC and CBD cannabis products, doses and times of use are most right for me?
Whether you’re in active treatment or a cancer survivor, our care team and products are here to help you realize more relief, more responsibly.
What are the benefits and risks of cannabis? Will it make me feel high or dizzy? What about my other meds? How can I use it most responsibly?
With EO, you can more easily and safely explore both CBD and THC - and find and maintain the cannabis regimen that’s most right for you.
Find out how we can more responsibly help relieve your employees’ cancer and cancer treatment related symptoms. While helping you significantly reduce the ever-increasing costs of symptom management.
The Administration’s decision to move to reclassify cannabis from Schedule I to Schedule III is a watershed moment for adult Americans who currently or might benefit from the responsible use of cannabinoids, especially oncology patients and older adults. It’s a long overdue step that will reduce stigma, open doors for essential research and product development, and increase access to care for patients.
As the leader in cannabinoid based symptom management for older adults, we applaud the Centers for Medicare & Medicaid Services (CMS) proposal to expand coverage for federally legal, hemp-derived cannabinoid-based products. At EO, we are uniquely positioned to meet the need of this new, covered cannabinoid care market.
At EO, we systematically track how patients feel and function after starting guided cannabis care. The data below come from real people using cannabis to manage symptoms such as pain, sleep disturbance, anxiety, and nausea/vomiting, under the guidance of our clinical protocols.
Get the latest product news, special offers and research/insights from our expert team.
Wise Use for All
© 2025 All rights reserved. Patents pending. EO Care, Inc.
